Msn Life Sciences Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SUGAMMADEX SODIUM, with a corresponding US DMF Number 33723.
Remarkably, this DMF maintains an Active status since its submission on March 29, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 16, 2019, and payment made on May 24, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II